| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | €8,9686 | +4,08% | €271,86M | €50,79K | |
FUND Sprott Focus Trust, Inc. | €9,3070 | +0,51% | €271,70M | €10,44K | |
FATE Fate Therapeutics, Inc. | €2,1201 | +1,43% | €271,57M | €494,54K | |
NMRA Neumora Therapeutics, Inc. Common Stock | €1,3063 | +0,00% | €271,40M | €167,12K | |
GALT Galectin Therapeutics Inc. | €3,3750 | +1,55% | €271,25M | €101,25K | |
NREF NexPoint Real Estate Finance, Inc. | €14,8277 | -1,59% | €271,23M | €12,84K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | €9,3070 | +0,32% | €270,98M | €13,70 | |
PSBD Palmer Square Capital BDC Inc. | €8,8238 | -0,76% | €270,96M | €44,75K | |
| €3,0366 | +13,99% | €270,76M | €1,31M | |
| €5,6364 | +2,33% | €270,58M | €30,18K | |
SMTI Sanara MedTech Inc. Common Stock | €29,5056 | +0,19% | €270,34M | €225,38K | |
MLP Maui Land & Pineapple Co. | €13,7818 | +2,09% | €270,31M | €3,30K | |
AFB Alliance National Municipal Income Fund, Inc. | €9,3584 | -0,05% | €270,11M | €23,50K | |
| €35,6971 | +1,67% | €270,08M | €7,74K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | €9,0286 | +0,09% | €270,08M | €155,17K | |
